The Week's Top News in Cannabis Stocks

: ACB | Aurora Cannabis Inc. News, Ratings, and Charts

ACB – A once very bearish analyst Bill Kirk at MKM Partners changed his tone immediately last week after CGC’s earnings.

 

After Canopy Growth (CGC) posted a positive earnings surprise in their quarterly report last Friday, the cannabis market has been relatively stable and a couple of stocks have seen shares rally higher this week.

A once very bearish analyst Bill Kirk at MKM Partners changed his tone immediately last week after CGC’s earnings. The change in analyst sentiment, along with interested bargain hunters, were some of the contributing factors that lead to the rise in cannabis stocks this week. 

 

Innovative Industrial Properties (IIPR)

Innovative Industrial Properties has been on a tear over the past few weeks as investors get ready for their Q4 2019 earnings next week.  Since December 2019, IIPR’s stock has run from $70 per share to well over $100.  Therefore, it’s easy to assume investors are expecting an earnings beat.

The company recently raised over $200 million after they issued more shares, and the market is clearly happy with what they are doing. Most of the time the market does not like when a company raises capital in the form of share issues, but that’s not the case for IIPR. The company has a clear path towards profitability and so far any capital they have raised has been put straight to work.

 

Aurora Cannabis (ACB)

Aurora Cannabis has been leading the charge this week for cannabis stocks after 

Last Friday Bill Kirk at MKM Partners gave ACB an upgrade, due to the improving balance sheet and ongoing changes within the company.  As a result, investors were buying shares of ACB this week and the stock is trading up roughly 10% over the past 5 days. 

ACB is currently in the hunt for a new permanent CEO, who investors are hoping he/she will be able to steer the company towards profitability. 

The company is also looking for an improvement in the Canadian retail market, especially in the nation’s most populous province of Ontario. Currently, the province has less than 100 stores when it was projected they should have closer to 1000. 

In addition, ACB also announced that they would be offering discount products that would further combat the black market. 

 

Australis Capital (AUSAF)

This week Australis Capital announced that they would be terminating their merger with Folium Biosciences. Australis Capital was launched in 2018 as Aurora Cannabis’s venture capital arm focused on investment in the United States cannabis market. The stock has been halted for weeks following the merger with Folium Biosciences and resumed trading on Thursday of this week on the OTC market. 

The company closed the trading day on Thursday down 26% on the merger termination news. Australis Capital will have a conference call for investors on the 26th of February as investors are eager to learn what really caused the company to terminate the merger. 

 

 


ACB shares were trading at $1.65 per share on Friday morning, down $0.03 (-1.79%). Year-to-date, ACB has declined -23.61%, versus a 3.87% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ACBGet RatingGet RatingGet Rating
CGCGet RatingGet RatingGet Rating
IIPRGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Should Investors BEWARE this Market?

The S&P 500 (SPY) has been on a tear since November 1st when the Fed started to make their dovish tilt opening the door to future rate cuts. Unfortunately they keep not happening and start date keeps getting pushed further and further out. That has many wondering if stocks are getting ahead of themselves setting things up for a fall. Thus a good time to tune into what investment veteran Steve Reitmeister has to say about the market outlook along with his trading plan and top picks to stay ahead of the pack. Read on below for more...

Top 4 Tech Giants Poised for Explosive Growth

Fueled by the ever-growing demand for advanced technological solutions across various sectors and ongoing innovation, the tech industry has robust growth prospects. Thus, it could be wise to invest in top tech stocks Dropbox (DBX), TTM Technologies (TTMI), Lantronix (LTRX) and AstroNova (ALOT) for potential growth. Continue reading…

3 Top Rated Software Stocks to Streamline Your Investments

The software industry is thriving with soaring demand, presenting ample investment opportunities. So, fundamentally solid software stocks ServiceNow (NOW), Autodesk (ADSK), and Docebo (DCBO) might be ideal buys for promising returns. Read on...

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading...

Is the Bull Market Growing Tired?

On the one hand it is fun to celebrate the new highs for the S&P 500 (SPY) that came in this Tuesday. On the other hand...it doesn’t make a lot of sense calling into question the next moves for the stock market. Read on below to appreciate investment veteran, Steve Reitmeister’s, market outlook and top picks to outperform.

Read More Stories

More Aurora Cannabis Inc. (ACB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ACB News